Cellectis (CLLS) EBITDA (2015 - 2026)
Cellectis (CLLS) posted EBITDA of -$19.11 million for Q2 2026, compared with -$4.57 million a year earlier.
Powered by 
Analysis
Cellectis (CLLS) EBITDA (2015 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBITDA at Cellectis was -$38.94 million; for FY2025, it came in at -$13.01 million.
- In prior years, Cellectis' EBITDA was -$39.71 million in FY2024, -$78.78 million in FY2023, -$71.23 million in FY2022 and -$89.33 million in FY2021.
- Quarterly EBITDA has run from a low of -$38 million in Q3 2021 to a high of $13.05 million in Q3 2025 over five years.
- According to Business Quant data, EBITDA for the three prior quarters was -$20.63 million (Q1 2026), -$12.25 million (Q4 2025) and $13.05 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 8.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 8.16 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 7.34 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 5.99 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 4.83 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 4.20 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 7.05 Bn |
| 10 | Cellectis | 111.38 Mn | -642.02 Mn | - | -19.11 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -19.11 Mn |
| Mar 31, 2026 | -20.63 Mn |
| Dec 31, 2025 | -12.25 Mn |
| Sep 30, 2025 | 13.05 Mn |
| Jun 30, 2025 | -4.57 Mn |
| Mar 31, 2025 | -9.25 Mn |
| Dec 31, 2024 | -4.85 Mn |
| Sep 30, 2024 | -6.05 Mn |
| Jun 30, 2024 | -12.48 Mn |
| Mar 31, 2024 | -16.33 Mn |
| Dec 31, 2023 | -24.40 Mn |
| Sep 30, 2023 | -16.21 Mn |
| Jun 30, 2023 | -19.20 Mn |
| Mar 31, 2023 | -18.98 Mn |
| Dec 31, 2022 | -933,000.00 |
| Sep 30, 2022 | -23.05 Mn |
| Jun 30, 2022 | -22.21 Mn |
| Mar 31, 2022 | -24.33 Mn |
| Dec 31, 2021 | -21.94 Mn |
| Sep 30, 2021 | -38.00 Mn |
API Access
Cellectis EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=CLLS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "CLLS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=CLLS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();